Identification of eukaryotic elongation factor-2 as a novel cellular target of lithium and glycogen synthase kinase-3

Mol Cell Neurosci. 2010 Dec;45(4):449-55. doi: 10.1016/j.mcn.2010.08.004. Epub 2010 Aug 12.

Abstract

Inhibition of glycogen synthase kinase-3 (GSK-3) is thought to be a major consequence of the biological and clinical activity of the mood stabilizer lithium, however, lithium and GSK-3 may activate distinct cellular pathways. We employed a proteomic method to uncover new downstream targets of lithium, and then examined how these proteins are related to GSK-3. Proteomic analysis identified eukaryotic elongation factor-2 (eEF-2) as a cellular target of lithium. This was verified in SH-SY5Y cells and animal models. In cells, lithium decreased eEF-2 phosphorylation at its key inhibitory site, threonine 56, and blocked the enhancement of eEF-2 phosphorylation normally coupled with stress conditions such as nutrient and serum deprivation. Unexpectedly, inhibition of GSK-3 enhanced eEF-2 phosphorylation, and overexpression of GSK-3α or GSK-3β resulted in a strong reduction in eEF-2 phosphorylation. Chronic administration of lithium reduced the hippocampal fraction of phospho-eEF-2 (phospho-eEF-2/total eEF-2) twofold in two different mouse strains. In summary, unexpectedly eEF-2 is activated by both lithium and GSK-3, whereas, lithium treatment and inhibition of GSK-3 have opposing effects on eEF-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology*
  • Cell Line
  • Electrophoresis, Gel, Two-Dimensional
  • Elongation Factor 2 Kinase / drug effects*
  • Elongation Factor 2 Kinase / metabolism
  • Glycogen Synthase Kinase 3 / drug effects*
  • Glycogen Synthase Kinase 3 / metabolism
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Humans
  • Lithium Compounds / pharmacology*
  • Mice
  • Mice, Inbred ICR
  • Phosphorylation

Substances

  • Antidepressive Agents
  • Lithium Compounds
  • EEF2K protein, human
  • Elongation Factor 2 Kinase
  • Glycogen Synthase Kinase 3